Novel dibenzo(B,F)oxepine-10-carboxamides and pharmaceutical uses thereof

Details for Australian Patent Application No. 2004263286 (hide)

Owner Novartis AG

Inventors Simic, Oliver; Betschart, Claudia; Vangrevelinghe, Eric; Glatthar, Ralf; Veenstra, Siem Jacob; Tintelnot-Blomley, Marina; Troxler, Thomas J.; Auberson, Yves; Flohr, Stefanie

Agent Davies Collison Cave

Pub. Number AU-B-2004263286

PCT Pub. Number WO2005/014517

Priority 0317491.9 25.07.03 GB

Filing date 23 July 2004

Wipo publication date 17 February 2005

Acceptance publication date 15 January 2009

International Classifications

C07C 235/82 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07D 313/14 (2006.01) Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 407/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 453/02 (2006.01) Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/014517 Priority application(s): WO2005/014517

15 January 2009 Application Accepted

  Published as AU-B-2004263286

14 May 2009 Standard Patent Sealed

17 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004263287-Substituted lactams and their use as anti-cancer agents

2004263285-Stable modifications of tegaserod hydrogen maleate